Debra L. Dugger

6.8k total citations · 3 hit papers
24 papers, 4.3k citations indexed

About

Debra L. Dugger is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Debra L. Dugger has authored 24 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Debra L. Dugger's work include Cell death mechanisms and regulation (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Ubiquitin and proteasome pathways (5 papers). Debra L. Dugger is often cited by papers focused on Cell death mechanisms and regulation (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Ubiquitin and proteasome pathways (5 papers). Debra L. Dugger collaborates with scholars based in United States, France and Australia. Debra L. Dugger's co-authors include Kim Newton, Vishva M. Dixit, Joshua D. Webster, Merone Roose‐Girma, Katherine E. Wickliffe, László G. Kömüves, Ralph Schwall, Allie Maltzman, Elaine Mai and Mark X. Sliwkowski and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Debra L. Dugger

23 papers receiving 4.2k citations

Hit Papers

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM... 2008 2026 2014 2020 2008 2014 2019 400 800 1.2k

Peers

Debra L. Dugger
Comparison fields: 5 of 125
  • Molecular Biology 2.7k
  • Oncology 1.7k
  • Radiology, Nuclear Medicine and Imaging 1.3k
  • Immunology 1.1k
  • Cancer Research 415
Replace Uwe Zangemeister‐Wittke with:
Uwe Zangemeister‐Wittke Switzerland
James N. Arnold United Kingdom
Wijnand Helfrich Netherlands
Klára Tótpál United States
Rebecca S. Cook United States
Delia Mezzanzanica Italy
Sophia N. Karagiannis United Kingdom
D Kufe United States
Heinz Läubli Switzerland
Moorthy P. Ponnusamy United States
Uwe Zangemeister‐Wittke Switzerland View profile →
Citations per field, relative to Debra L. Dugger
Debra L. Dugger · 1×
Citations per year, relative to Debra L. Dugger
Debra L. Dugger · 1×

Countries citing papers authored by Debra L. Dugger

Since Specialization
Citations

This map shows the geographic impact of Debra L. Dugger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra L. Dugger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra L. Dugger more than expected).

Fields of papers citing papers by Debra L. Dugger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra L. Dugger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra L. Dugger. The network helps show where Debra L. Dugger may publish in the future.

Co-authorship network of co-authors of Debra L. Dugger

This figure shows the co-authorship network connecting the top 25 collaborators of Debra L. Dugger. A scholar is included among the top collaborators of Debra L. Dugger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra L. Dugger. Debra L. Dugger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 0
3 8
4 5
5 54
6 107
7 71
8
Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis breakdown →
407
9 289
10 54
11 49
12 307
13 46
14
Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis breakdown →
531
15 214
16 90
17 473
18
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate breakdown →
1259
19
Trastuzumab-MC-vc-PAB-MMAF: The effects of the Drug:Antibody Ratio (DAR) on efficacy, toxicity and pharmacokinetics.
3
20 82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026